文献速递慢性静脉疾病

氰基丙烯酸酯栓塞与腔内激光消融大隐静脉后的超声表现比较

A comparison of duplex ultrasound findings after cyanoacrylate embolization versus endovenous laser ablation of the great saphenous vein.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2019-09-05

本研究回顾性匹配比较氰基丙烯酸酯栓塞(CAE)与腔内激光消融(EVLA)治疗大隐静脉(GSV)后的超声变化及临床结局。481例中119例术后复查超声,CAE后胶铸型至少留存3年且静脉直径缩小未达统计学意义,EVLA后静脉逐渐不可见;两组解剖复发率无显著差异。

要点

  • CAE后胶铸型至少留存3年,降解比预期慢。
  • EVLA后静脉组织重塑,随访>2年>80%无可见静脉段。
  • CAE与EVLA解剖复发率无统计学显著差异。

核心结论

  • CAE后胶铸型至少留存3年,降解过程比预期慢。
  • EVLA后静脉组织重塑并随时间不可见。
  • CAE与EVLA解剖复发率无统计学显著差异。

研究设计与样本

  • 回顾性匹配研究,CAE与EVLA按手术时间和静脉直径匹配。
  • 481例 eligible 患者中119例接受术后超声复查。

主要发现

  • CAE患者静脉直径随时间有缩小趋势,但中段大腿(P = .32)和膝部(P = .511)未达统计学意义。
  • EVLA患者随访间隔增加,中段大腿(P = .046)和膝部(P = .038)静脉显示频率降低。
  • 随访>2年,>80% EVLA患者无可见静脉段。
  • 解剖复发率CAE 10.5%、EVLA 8.2%,差异无统计学意义(P = .60)。
  • 多数复发见于功能不全的属支存在时。

临床怎么用

  • CAE是GSV功能不全的可选治疗,但胶铸型长期留存需延长随访。
  • EVLA后静脉随时间不可见,复发多与功能不全属支相关。

局限性

  • 回顾性图表回顾,仅119/481例有术后超声复查。
  • 随访时间和间隔可能影响静脉显示与复发评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whereas numerous studies have demonstrated noninferiority of cyanoacrylate embolization (CAE) relative to endovenous laser ablation (EVLA), little is known about the natural history of the vein or the glue that is implanted. This study provides the first description of duplex ultrasound changes of the great saphenous vein (GSV) after CAE relative to EVLA as well as a pragmatic view of outcomes in clinical practice. METHODS: Patients treated with CAE and EVLA at our institution were matched by time of procedure and vein size. GSV diameter was measured at the saphenofemoral junction, midthigh, and knee. Duplex ultrasound imaging was repeated after treatment in the same noninvasive laboratory with an identical protocol. Clinical data were collected by retrospective chart review. RESULTS: Of 481 eligible patients, 119 underwent postoperative duplex ultrasound imaging. Although there was a trend toward decreased vein diameter over time in CAE patients relative to their preoperative vein diameter, this failed to reach statistical significance at the midthigh (P = .32) or at the knee (P = .511). In EVLA patients, as follow-up interval increased, the vein was less frequently visualized on ultrasound at the midthigh (P = .046) and knee (P = .038). At >2 years of follow-up, >80% of EVLA patients had no visible vein segment. Anatomic recurrence was observed in 10.5% of CAE patients and 8.2% of EVLA patients, which was not statistically significantly different (P = .60). The majority of recurrence was observed in the presence of incompetent tributaries. CONCLUSIONS: After CAE of the GSV, our results indicate that the glue cast remains for at least 3 years. Although our results suggest that the glue is broken down over time, this process is much slower than expected. In contrast, after EVLA, the vein tissue is remodeled and is no longer visible with time. In our study, which represents a pragmatic clinical population with a large (median, 9.2 mm) vein diameter, we again demonstrate no statistically significant difference in recurrence rates. Whereas CAE offers an attractive treatment option for GSV incompetence, the glue cast remains for a prolonged time, and longer follow-up studies than those currently available are indicated.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. McGuinness B, Elias F, Ali KP, et al. A comparison of duplex ultrasound findings after cyanoacrylate embolization versus endovenous laser ablation of the great saphenous vein. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31495764. doi:10.1016/j.jvsv.2019.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。